Discover Pharmaceutical Sciences

Springer Nature

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

Discover Pharmaceutical Sciences is an open-access journal published by Springer Nature in Singapore, publishing in english. It is listed in DOAJ according to the sources read. Declared publication charge: 1,090 EUR. Declared review time at DOAJ: 18 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Springer Nature
ISSN
3005-1835
Country
Singapore
Languages
english
Access
Open access
Declared publication charge
1,090 EUR
Articles in DOAJ
31
Declared review time
18 weeks
Declared peer-review model
peer_review

Index listings

  • DOAJ · 2025-09-05
Indexing
DOAJ
APC
1,090 EUR
Declared review time (DOAJ)
18 weeks — journal-declared only (not measured)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

31

Most recent article

last month

Average review time (journal-declared via DOAJ)

18weeks

Works in OpenAlex

42

Last recorded publication year

2026

Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

7

i10-index

2

From OpenAlex open data (CC0).

Editorial & policy12
Last DOAJ review date
2026-03-17
Added to DOAJ
2025-09-05
Declared plagiarism screening
Declared
Other fees beyond APC
No
Declared digital preservation
CLOCKSSPortico
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Editorial board
Official page ↗
Open references deposited at Crossref
98%
ORCID iDs in current deposits
36%
Enrolled in Crossref Similarity Check
✓
Deposits licence metadata at Crossref
✓
APC waiver policy
View policy
Peer-review policy
View policy
Identity & continuity1
Source type
journal
Classification6

Subjects (DOAJ)

Medicine: Therapeutics. PharmacologyMedicine: Pharmacy and materia medicaSocial Sciences: Industries. Land use. Labor: Special industries and trades: Pharmaceutical industry

LCC codes

RM1-950RS1-441HD9665-9675

Subject areas

  • Advancements in Transdermal Drug Delivery
  • Advancements in Transdermal Drug Delivery
  • Computational Drug Discovery Methods
  • Computational Drug Discovery Methods
  • Drug Solubulity and Delivery Systems
  • Natural product bioactivities and synthesis
  • Drug Solubulity and Delivery Systems
  • Phytochemical compounds biological activities
Show all subjects (50)
  • Advanced Drug Delivery Systems
  • Natural Antidiabetic Agents Studies
  • Nanoparticle-Based Drug Delivery
  • Phytochemical compounds biological activities
  • Extracellular vesicles in disease
  • Medicinal Plants and Neuroprotection
  • Advanced Drug Delivery Systems
  • Natural product bioactivities and synthesis
  • Nanoparticle-Based Drug Delivery
  • Ethnobotanical and Medicinal Plants Studies
  • Genetics, Bioinformatics, and Biomedical Research
  • RNA Interference and Gene Delivery
  • Lipid Membrane Structure and Behavior
  • Pharmaceutical Economics and Policy
  • Nanoparticles: synthesis and applications
  • Dermatology and Skin Diseases
  • Wound Healing and Treatments
  • Diabetes Treatment and Management
  • Phytochemicals and Antioxidant Activities
  • Silymarin and Mushroom Poisoning
  • Ethnobotanical and Medicinal Plants Studies
  • Drug-Induced Adverse Reactions
  • Pharmacovigilance and Adverse Drug Reactions
  • Phytochemistry and Bioactivity Studies
  • Pharmaceutical studies and practices
  • Extracellular vesicles in disease
  • RNA Interference and Gene Delivery
  • Genetics, Bioinformatics, and Biomedical Research
  • Lipid Membrane Structure and Behavior
  • Pharmaceutical Economics and Policy
  • Nanoparticles: synthesis and applications
  • Pharmaceutical studies and practices
  • Medicinal Plants and Neuroprotection
  • Phytochemicals and Antioxidant Activities
  • Diabetes Treatment and Management
  • Dermatology and Skin Diseases
  • Drug-Induced Adverse Reactions
  • Natural Antidiabetic Agents Studies
  • Silymarin and Mushroom Poisoning
  • Pharmacovigilance and Adverse Drug Reactions
  • Phytochemistry and Bioactivity Studies
  • Protein Structure and Dynamics

Keywords (DOAJ)

  • drug delivery
  • drug discovery
  • pharmacokinetics
  • clinical pharmacology
  • drug metabolism
  • pharmacogenomics

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: